Polymorphism of the ABO gene associate with thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria.

about

Polymorphism of the ABO gene associate with thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria.

Item

http://www.wikidata.org/entity/Q46683290

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Polymorphism of the ABO gene a ...... smal nocturnal hemoglobinuria.

@en

Polymorphism of the ABO gene a ...... smal nocturnal hemoglobinuria.

@nl

type

Item

label

Polymorphism of the ABO gene a ...... smal nocturnal hemoglobinuria.

@en

Polymorphism of the ABO gene a ...... smal nocturnal hemoglobinuria.

@nl

prefLabel

Polymorphism of the ABO gene a ...... smal nocturnal hemoglobinuria.

@en

Polymorphism of the ABO gene a ...... smal nocturnal hemoglobinuria.

@nl

P1476

Polymorphism of the ABO gene a ...... smal nocturnal hemoglobinuria.

@en

P2093

Bing Han

http://www.w3.org/2001/XMLSchema#string

Hongmin Li

http://www.w3.org/2001/XMLSchema#string

Yali Du

http://www.w3.org/2001/XMLSchema#string

Zhangbiao Long

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

Thrombosis in paroxysmal nocturnal hemoglobinuria

The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review

Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.

Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH).

Genomic organization of human histo-blood group ABO genes.

Paroxysmal nocturnal hemoglobinuria

Narrative review: paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia.

Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism

P304

92411-92419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21361

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29190926

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

P932

5696192

http://www.w3.org/2001/XMLSchema#string